Please ensure Javascript is enabled for purposes of website accessibility

1 Wall Street Pro Heats Up on CoolSculpting Artist Zeltiq Aesthetics

By Rick Munarriz – Sep 21, 2016 at 4:13PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Stifel boosts its price target on the company that's freezing fat cells off, encouraged by a future of improving margins, earnings, and prospects.

Image source: Zeltiq Aesthetics.  

Zeltiq Aesthetics (ZLTQ) hit another all-time high last week, and one analyst thinks that the company behind the CoolSculpting machines that freeze away fat cells is heading even higher. Stifel analyst Jonathan Block is boosting his price target on the stock from $38 to $52. He is sticking with his buy rating.  

The move makes sense on the surface. The stock has closed above $38 for eight consecutive trading days now. It's hard to cling to a bullish rating with a price target that is below where the stock is at these days. Block is justifying his revision based on improving margins and profitability.

Zeltiq generates revenue from the initial sale of machines and accessories, but it also cashes in on higher-margin consumable revenue whenever the machine is put into use. It's a segment that's growing a lot faster than system revenue, up 54% over the past year relative to a 23% increase in system revenue. Consumable revenue is now accounting for 56% of Zeltiq's total revenue, but Block sees recurring revenue growing to 70% of sales by 2018.   

Cool places

Year-over-year revenue growth decelerated to 25% during this year's first quarter, Zeltiq's slowest growth in three years. The CoolSculpting parent went on to bounce back in the second quarter with its top line soaring 39%, its headiest growth in more than a year.

There are now 5,254 CoolSculpting systems in its installed base, and they are being put to good use. There have now been nearly 3 million CoolSculpting sessions performed with 370,122 of them coming during its latest quarter alone. High customer satisfaction rates for the non-invasive procedure are encouraging dermatologists, physicians, and weight loss center operators to consider the purchase. 

Zeltiq has made a smart investment seem even smarter by gaining clearance for treatment in new body areas. It has also rolled out add-on applicators that speed up the process, allowing treatment centers to go through more appointments. 

The one dark cloud this year has been shrinking margins. New products and heavier marketing expenses have weighed on bottom-line results, but Stifel's Block sees a sharp improvement in margins next year. 

Zeltiq is doing right by Wall Street. The company keeps boosting its top-line guidance with every passing quarter. This makes it easy for analysts to warm up to the growth stock, especially those Wall Street pros that see the near-term bottom-line challenges as being a mere temporary setback. Investors will want to naturally keep an eye on the revenue cycles for any signs of a slowdown in popularity, but for now CoolSculpting as a treatment and Zeltiq Aesthetics as a stock keep moving in the right direction.

Rick Munarriz owns shares of Zeltiq Aesthetics. The Motley Fool recommends Zeltiq Aesthetics. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

ZELTIQ Aesthetics, Inc. Stock Quote
ZELTIQ Aesthetics, Inc.
ZLTQ

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
351%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 11/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.